Skip to main content

Table 3 Multivariate analysis for LCP and OS

From: Intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for stage I-II natural killer/T-cell lymphoma nasal type: dosimetric and clinical results

Factor

OS

 

LCP

 
 

Hazard ratio

p value

Hazard ratio

p value

 

(95% CI)

 

(95% CI)

 

IMRT

1.12(0.43–2.93)

0.81

1.05(0.31–3.59)

0.94

ECOG score =2

2.59(1.08–6.22)

0.03

2.23(0.76–6.54)

0.02

LDH elevated¶

3.05(1.03–9.06)

0.04

–

–

Stage = II±

–

–

2.10(0.29–15.00)

0.46

Nasal cavity lesions with extensive invasion&

1.30(0.83–2.06)

0.25

1.04(0.54–2.00)

0.92

Stage-modified IPI=2-3

0.95(0.40–2.24)

0.91

1.14(0.36–3.65)

0.83

  1. ¶LDH elevation was accounted for in the multivariate analysis for LCP, but not for OS.
  2. ±Stage = 2 was accounted for in the multivariate analysis for OS, but not for LCP.
  3. &Nasal cavity lesions with extensive invasion: the tumor invaded nasal cavity and two or more neighboring anatomic structures(pnasal sinuses, nasopharynx, oropharynx or laryngopharynx).